Loading clinical trials...
Loading clinical trials...
Assessing Completion of Medication Abortion for Very Early Pregnancies
This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.
Age
All ages
Sex
FEMALE
Healthy Volunteers
No
Carafem
Atlanta, Georgia, United States
Carafem
Chevy Chase, Maryland, United States
Cedar River Clinics
Renton, Washington, United States
Start Date
March 13, 2025
Primary Completion Date
March 1, 2026
Completion Date
April 1, 2026
Last Updated
June 5, 2025
400
ESTIMATED participants
Weekly high-sensitivity urine pregnancy tests
DIAGNOSTIC_TEST
Lead Sponsor
University of Washington
NCT06768060
NCT07462065
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06273683